PImininingwane yomzila:
Ukubukeka | I-crystal powder emhlophe noma emhlophe |
Ukulahlekelwa ekomisweni | Hhayi ngaphezu kuka-1.0% |
Umlotha we-sulphate | Hhayi ngaphezu kuka-1.0% |
I-L-lysine | Hhayi ngaphezu kuka-1.2% |
Ukuzungezisa okuqondile(C=1 2N ku-HCL) | +16° ukuya +20° |
Amanzi | Hhayi ngaphezu kuka-0.5% |
Isivivinyo | 99.0% kuya ku-101.0% |
Isitoreji | Gcina endaweni emnyama, evalwe endaweni eyomile, Emazingeni Okushisa Egumbi |
Iphakheji | 25kg/ isigubhu |
Isikhathi sokuqinisekisa | iminyaka engu-2 |
Ezokuthutha | ngolwandle noma emoyeni noma emhlabeni |
Izwe azalelwe kulo | China |
Imigomo yokukhokha | T/T |
Omqondofana:
NεI-Trifluoroacetyl-L-lysine;
(2S) -2-amino-6-[(2,2,2-trifluoroacetyl)amino]hexanoic acid;
(S) -2-Amino-6-pivalamidohexanoic acid;
I-N6-Trifluoroacetyl-L-lysine;
I-Nepsilon-Trifluoroacetyl-L-lysine;
N(6)-trifluoroacetyl-L-lysine;
ε-TFA-lysine;
Isicelo:
Isetshenziswa njengomuthi ophakathi we-lisinopril.
Ubukhulu:
1. Ngokuvamile sinezinga lethani esitokweni, futhi singaletha impahla ngokushesha ngemva kokuthola i-oda.
2. Ikhwalithi ephezulu kanye nentengo yokuncintisana inganikezwa.
3.Umbiko wokuhlaziywa kwekhwalithi (COA) wenqwaba yokuthunyelwa uzonikezwa ngaphambi kokuthunyelwa.
4. Uhlu lwemibuzo yabahlinzeki kanye nemibhalo yezobuchwepheshe inganikezwa uma isicelo emva kokuhlangabezana nenani elithile.
5. Isevisi enhle yangemuva kokuthengisa noma isiqinisekiso : Noma yimuphi umbuzo wakho uzoxazululwa ngokushesha okukhulu.